Literature DB >> 3315146

Environmental risk factors for Parkinson's disease: the epidemiologic evidence.

B S Schoenberg1.   

Abstract

Descriptive data from several studies suggest variations in the frequency of Parkinson's disease in different population groups. Door-to-door surveys were carried out among a biracial U.S. population (blacks and whites) and in communities in Nigeria and the People's Republic of China. The U.S. investigation revealed no substantial differences in the age-adjusted prevalence ratios by race. However, blacks in Nigeria have a much lower prevalence ratio than blacks in the U.S., suggesting an environmental etiologic factor. Prevalence ratios derived from China are also lower than the U.S. figures. Studies of temporal trends in the incidence rates in one U.S. population (Rochester, Minnesota) show virtually no change over 35 years, indicating that the primary cause(s) of Parkinson's disease must have been present in this nonindustrialized community for many years. Analytic studies generally reveal an inverse association between Parkinson's disease and cigarette smoking, although epidemiologic evidence does not support a direct protective effect of smoking. Preliminary investigations suggest an increased risk associated with the rural environment and the consumption of well water. Further studies are required to discover as yet unknown environmental factors that heighten the risk of Parkinson's disease.

Entities:  

Mesh:

Year:  1987        PMID: 3315146     DOI: 10.1017/s0317167100037811

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  9 in total

1.  Is Parkinson's disease of early onset a separate disease entity?

Authors:  S M Ludin; H P Ludin
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849

Review 2.  The epidemiology of primary degenerative dementia and related neurological disorders.

Authors:  B Cooper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

3.  Perspective: Low Risk of Parkinson's Disease in Quasi-Vegan Cultures May Reflect GCN2-Mediated Upregulation of Parkin.

Authors:  Mark F McCarty; Aaron Lerner
Journal:  Adv Nutr       Date:  2021-03-31       Impact factor: 8.701

4.  Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's disorders?

Authors:  Moussa B H Youdim
Journal:  Rambam Maimonides Med J       Date:  2010-10-31

5.  Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents.

Authors:  Moussa B H Youdim
Journal:  Exp Neurobiol       Date:  2010-06-30       Impact factor: 3.261

Review 6.  Bioactivity of Olive Oil Phenols in Neuroprotection.

Authors:  Cristina Angeloni; Marco Malaguti; Maria Cristina Barbalace; Silvana Hrelia
Journal:  Int J Mol Sci       Date:  2017-10-25       Impact factor: 5.923

Review 7.  Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson's Disease.

Authors:  Mark F McCarty; Aaron Lerner
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

8.  Well-Water Consumption and Risk of Parkinson's Disease: A Meta-Analysis of 15 Observational Studies.

Authors:  Yanni Shi; Kezhong Zhang; Ming Ye
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-16       Impact factor: 2.570

Review 9.  Sulforaphane as a potential protective phytochemical against neurodegenerative diseases.

Authors:  Andrea Tarozzi; Cristina Angeloni; Marco Malaguti; Fabiana Morroni; Silvana Hrelia; Patrizia Hrelia
Journal:  Oxid Med Cell Longev       Date:  2013-07-25       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.